Steven Shoptaw, PhD (Faculty Mentor) is a Clinical Psychologist, Professor of Family Medicine in the UCLA DGSOM, and Co-Director of the Center for HIV Prevention and Treatment Services (CHIPTS). Dr. Shoptaw’s research uses behavioral and biomedical strategies to address the link between substance use and HIV risk. He is also a member of the Executive Committee of the HIV Prevention Trials Network, leading efforts to address the high incidence of HIV infection among African-American and Latino MSM in the Los Angeles area.
Substance use and HIV prevention
Pharmacologic treatment of substance use
Selected Recent Publications:
Brensilver, M., Heinzerling, K.G., Shoptaw, S. Pharmacotherapy of amphetamine-type stimulant dependence: An update. Drug Alcohol Rev. 2013 Sep; 32(5):449-60.
Shoptaw, S., et al. Not just the needle: the state of HIV-prevention science among substance users and future directions. J Acquir Immune Defic Syndr 2013; 63:S174-S178.
2. Carrico, A.W., Shoptaw, S., et al. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Dec 15, 67(5), 508-513.
Reback, C.J., Shoptaw, S. Getting Off: Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addictive Behaviors. 2014 Aug;39(8):1286-91.
The priority application deadline is Friday, January 10th, 2020.